Pharmacokinetics and Safety of Amenamevir in Healthy Subjects: Analysis of Four Randomized Phase 1 Studies


INTRODUCTION Amenamevir (ASP2151) is a nonnucleoside antiherpesvirus compound available for the treatment of varicella-zoster virus infections. In this article we summarize the findings of four phase 1 studies in healthy participants. METHODS Four randomized phase 1 studies investigated the safety and pharmacokinetics of single and multiple doses of… (More)
DOI: 10.1007/s12325-017-0642-4


Figures and Tables

Sorry, we couldn't extract any figures or tables for this paper.